WallStreetZenWallStreetZen

NASDAQ: HEPA
Hepion Pharmaceuticals Inc Earnings & Revenue

HEPA earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$38.5M
Current Profit Margin
0%

HEPA Return on Equity

Current Company
-268.7%
Current Industry
16.8%
Current Market
28.2%
HEPA's Return on Equity (-268.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when HEPA announces earnings.

HEPA Return on Assets

Current Company
-161.2%
Current Industry
3.2%
HEPA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

HEPA Return on Capital Employed

Current Company
-312.23%
Current Industry
-42.4%
HEPA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HEPA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
HEPA$0.00-$41.81M-$38.52MN/AN/A
PYPD$0.00-$21.05M-$23.87MN/A+28.76%
CMND$0.00-$6.66M-$6.92MN/AN/A
BCDA$468.00k-$9.92M-$10.34M-6.13%N/A
TFFP$885.72k-$19.41M-$19.93M+328.43%N/A

HEPA earnings dates

Next earnings date
Aug 12, 2024

Hepion Pharmaceuticals Earnings & Revenue FAQ

What were HEPA's earnings last quarter?

On Invalid Date, Hepion Pharmaceuticals (NASDAQ: HEPA) reported Q1 2024 earnings per share (EPS) of -$0.56, up 83.91% year over year. Total Hepion Pharmaceuticals earnings for the quarter were -$2.85 million. In the same quarter last year, Hepion Pharmaceuticals's earnings per share (EPS) was -$3.48.

If you're new to stock investing, here's how to buy Hepion Pharmaceuticals stock.

What was HEPA's earnings growth in the past year?

As of Q3 2024, Hepion Pharmaceuticals's earnings has grown year over year. Hepion Pharmaceuticals's earnings in the past year totalled -$38.52 million.

What is HEPA's earnings date?

Hepion Pharmaceuticals's earnings date is Invalid Date. Add HEPA to your watchlist to be reminded of HEPA's next earnings announcement.

What was HEPA's revenue last quarter?

On Invalid Date, Hepion Pharmaceuticals (NASDAQ: HEPA) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Hepion Pharmaceuticals's revenue was $0.00.

What was HEPA's revenue growth in the past year?

As of Q3 2024, Hepion Pharmaceuticals's revenue has grown null year over year. Hepion Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.